0000914190-21-000185.txt : 20210616
0000914190-21-000185.hdr.sgml : 20210616
20210616192216
ACCESSION NUMBER: 0000914190-21-000185
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210614
FILED AS OF DATE: 20210616
DATE AS OF CHANGE: 20210616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kummeth Charles R.
CENTRAL INDEX KEY: 0001534980
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 211022863
MAIL ADDRESS:
STREET 1: 425 MARTINGALE ROAD
STREET 2: SUITE 1000
CITY: SCHAUMBURG
STATE: IL
ZIP: 60173-2213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-06-14
0000842023
BIO-TECHNE Corp
TECH
0001534980
Kummeth Charles R.
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
1
1
0
0
Chief Executive Officer
Common Stock
2021-06-14
4
S
0
7132
449.1
D
167253
D
Common Stock
2021-06-14
4
S
0
349
450.1
D
166904
D
Common Stock
100
I
By Step-Son
Common Stock
100
I
By Step-Daughter
Stock Options (Right to Buy)
108.49
2022-08-07
Common Stock
95346
95346
D
Stock Options (Right to Buy)
108.49
2022-08-07
Common Stock
79517
79517
D
Stock Options (Right to Buy)
106.59
2023-08-18
Common Stock
154169
154169
D
Stock Options (Right to Buy)
106.59
2023-08-18
Common Stock
102779
102779
D
Stock Options (Right to Buy)
125.05
2024-08-09
Common Stock
117342
117342
D
Stock Options (Right to Buy)
125.05
2024-08-09
Common Stock
78228
78228
D
Restricted Stock Units
Common Stock
16918
16918
D
Stock Options (Right to Buy)
177.32
2025-08-08
Common Stock
90334
90334
D
Stock Options (Right to Buy)
177.32
2025-08-08
Common Stock
60222
60222
D
Restricted Stock Units
Common Stock
16937
16937
D
Stock Options (Right to Buy)
190.41
2026-08-07
Common Stock
85725
85725
D
Stock Options (Right to Buy)
190.41
2026-08-07
Common Stock
57150
57150
D
Restricted Stock Units
Common Stock
12879
12879
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
57442
57442
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
38295
38295
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
16650.0
16650.0
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
16650
16650
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $449.00 to $449.97, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023.
Fully exercisable.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Options to purchase 19,557 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and 8/9/2021.
Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 15,056 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 15,055 shares vest on each of 8/8/2021 and 8/8/2022.
Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 8/7/2023.
Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 9,573 shares vest on 8/5/21 and options to purchase 9,574 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
Options to purchase 5,550 shares vest on each of 8/5/21, 8/5/22 and 8/5/23.
/s/ Brenda S. Furlow as Attorney-in-Fact for Charles R. Kummeth pursuant to Power of Attorney previously filed.
2021-06-16